Find out whether you are infected with SARS-CoV-2
QuickVue At-Home OTC COVID-19 Test
This FDA-authorized rapid antigen serial test enables you to collect and test your sample at home and receive results in just 10 minutes. The serial test is intended to be used twice over two to three days, with at least 24 hours and no more than 36 hours between tests.
Nucleocapsid antigens from SARS-CoV-2
Gentle lower nasal swab for easy self-collection
$25
This test is currently unavailable.
We accept HSA/FSA payments.
SARS-CoV-2 Coronavirus
The QuickVue At-Home OTC COVID-19 Test is testing for the presence or absence of nucleocapsid antigens from SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2), which causes the disease Coronavirus Disease 2019 (COVID-19).
This is not an antibody test.
This is not an antibody test.
This test is authorized for symptomatic or asymptomatic individuals aged 2+ (ages 2-13 require adult-assisted collection whereas, ages 14+ can self-collect).
Not intended for individuals experiencing severe COVID-19 symptoms who should seek emergency medical care right away.
Promotions and discounts do not apply.
General Symptoms
- • Fever between 100.4°F - 102°F
- • Flu-like symptoms (chills, runny or stuffy nose, whole body aches, a headache, and/or feeling tired)
- • New loss of taste or smell
Respiratory Symptoms
- • A new or worsening cough or sore throat
- • Coughing
- • Shortness of breath
Everything you need to collect and test your sample and understand your results
- Detailed directions to guide you
- All materials for two sample collections
- Results in just 10 minutes
- Care support available if needed
FDA authorized & actionable
The QuickVue At-Home OTC COVID-19 Test meets all accuracy requirements as defined by the FDA. The performance was measured during a clinical study that compared the QuickVue At-Home OTC COVID-19 Test results to an FDA Emergency Use Authorized high sensitivity PCR (molecular) test. Positive Percent Agreement (PPA) and Negative Percent Agreement (NPA) for both symptomatic and asymptomatic individuals were 83.5% and 99.2%, respectively.
This product has not been FDA cleared or approved but has been authorized by FDA under an Emergency Use Authorization (EUA). This product has been authorized only for the detection of proteins from SARS- CoV-2, not for any other viruses or pathogens. This product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. §360bbb-3(b)(1), unless the declaration is terminated or authorization is revoked sooner.
Letter of AuthorizationThis product has not been FDA cleared or approved but has been authorized by FDA under an Emergency Use Authorization (EUA). This product has been authorized only for the detection of proteins from SARS- CoV-2, not for any other viruses or pathogens. This product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. §360bbb-3(b)(1), unless the declaration is terminated or authorization is revoked sooner.
Affordable
For purchases made after January 15th, 2022, the QuickVue At-Home OTC COVID-19 Test is eligible for reimbursement up to $12 per individual test with private health insurance. Once your order is complete, you can contact your health insurance provider for reimbursement. Always check with your insurance provider to verify benefits coverage before purchase. Everlywell is not enrolled in the Medicare program, and this test is ineligible for Medicare reimbursement, but may be eligible for Medicare Advantage reimbursement.
Promotions and discounts do not apply.
Please refer to our refund policy here.
Steps for reimbursementPromotions and discounts do not apply.
Please refer to our refund policy here.
Questions?
Coronavirus disease (also called COVID-19) is an infection caused by SARS-CoV-2 (severe acute respiratory syndrome coronavirus), one of the most recently discovered types of coronaviruses. Those who have this disease may or may not experience COVID-19 symptoms, which range from mild to severe.
People with COVID-19 have had a wide range of symptoms reported – ranging from mild symptoms to severe illness. Some people do not show symptoms at all.
Symptoms may appear 2-14 days after exposure to the virus. People with these symptoms may have COVID-19:
This list is not all possible symptoms. Other less common symptoms have been reported, including gastrointestinal symptoms like nausea, vomiting, or diarrhea.
Symptoms may appear 2-14 days after exposure to the virus. People with these symptoms may have COVID-19:
- Cough
- Shortness of breath or difficulty breathing
- Fever
- Chills
- Muscle pain
- Sore throat
- New loss of taste or smell
This list is not all possible symptoms. Other less common symptoms have been reported, including gastrointestinal symptoms like nausea, vomiting, or diarrhea.
The following people are considered high risk for severe disease:
- People aged 65 and older
- People in nursing homes or long-term care facilities
- People of all ages with underlying medical conditions, particularly if they are not well controlled:
- Cancer
- Chronic obstructive pulmonary disease
- Chronic kidney disease
- Immunosuppressed following solid organ transplant
- Obesity (BMI >30)
- Serious heart conditions such as heart failure, coronary artery disease or cardiomyopathies
- Sickle cell disease
- Type II Diabetes
- People may be at increased risk due to the following conditions:
- Asthma (moderate-severe)
- Cerebrovascular disease (affecting blood vessels to the brain)
- Cystic fibrosis
- High blood pressure
- Immunocompromised (weakened immune system) from blood or bone marrow transplants, immune deficiencies, HIV, use of corticosteroids, use of other immune weakening medications
- Neurologic conditions such as dementia
- Liver disease
- Pulmonary fibrosis
- Smoking
- Thalassemia
- Type I Diabetes
The QuickVue At-Home OTC COVID-19 Test is a type of test called an antigen test. When you have COVID-19, SARS-CoV-2 (the virus that causes COVID-19) can be present in your nasal secretions. The QuickVue At-Home OTC COVID-19 Test can detect small parts of SARS-CoV-2 virus in your nasal secretions. These small parts of the SARS-CoV-2 virus are known as proteins or antigens.
No. This test is not yet approved or cleared by the United States FDA. When there are no FDA-approved or cleared tests available, and other criteria are met, FDA can make tests available under an emergency access mechanism called an Emergency Use Authorization (EUA). The EUA for this test is supported by the Secretary of Health and Human Services’ (HHS’s) declaration that circumstances exist to justify the emergency use of in vitro diagnostics (IVDs) for the detection and/or diagnosis of the virus that causes COVID-19. This EUA will remain in effect (meaning this test can be used) for the duration of the COVID-19 declaration justifying emergency use of IVDs, unless it is terminated or revoked by FDA (after which the test may no longer be used).
There are different kinds of tests for diagnosing COVID-19. Molecular tests detect genetic material from the virus. The QuickVue At-Home OTC COVID-19 Test is a rapid antigen test that detects small parts or proteins from the virus. Antigen tests are very specific for the virus but are not as sensitive as molecular tests. Another type of test is an antibody test. A COVID-19 antibody test detects antibodies that have been made by your immune system in response to a previous COVID-19 infection. Antibody tests are not suitable to diagnose an active COVID-19 infection. You can find more information about COVID-19 testing from the FDA website.
A positive test result means it is very likely that you have COVID-19 if you have symptoms because proteins from the virus that causes COVID-19 were found in your sample. You should self-isolate at home as per CDC recommendations to stop spreading the virus to others.
If you have received a positive test result, especially if you are considered high risk (please see FAQ ‘Who is considered high risk for severe disease?'), you should take the following steps:
Consult a healthcare provider as soon as possible. Please tell them that you tested positive for COVID-19. Provide your healthcare provider with:
If you have received a positive test result, especially if you are considered high risk (please see FAQ ‘Who is considered high risk for severe disease?'), you should take the following steps:
Consult a healthcare provider as soon as possible. Please tell them that you tested positive for COVID-19. Provide your healthcare provider with:
- Your Test Result
- The Fact Sheet for Healthcare Professionals
- Please consult the CDC recommendations regarding self-isolation
- There is a chance that this test can give a positive result that is wrong (a false positive result), especially if you use the test when there are very few COVID-19 infections in your local community. Your healthcare provider will work with you to determine how best to care for you based on the test results along with your medical history, and your symptoms.
A negative test result indicates that you are unlikely to currently have COVID-19 disease. A negative test result means that proteins, which are small parts of the virus that causes COVID-19, were not found in your sample.
However, it is possible for this test to give a negative result that is incorrect (false negative) in some people with COVID-19. This means that you could possibly still have COVID- 19 even though the test is negative. If your test result is negative, your healthcare provider will consider the test result together with all other aspects of your medical history (such as symptoms, vaccine status, possible exposures, and geographical location of places you have recently traveled) in deciding how to care for you.
The amount of antigen in a sample may decrease as the duration of illness increases. As days post-symptom onset increase, antigen test results may be more likely to be negative compared to a molecular SARS-CoV-2 test. You may also test negative at the very beginning of your infection before you develop symptoms.
If you are unwell, your symptoms are worsening, you develop new symptoms, or you are concerned, it is important that you see your healthcare provider, especially if you belong to a high-risk group (please see FAQ “Who is considered high risk for severe disease?”). Your healthcare provider will consider the test result with all other aspects of your medical history (such as symptoms, vaccine status, possible exposures, local community spread, and places you have recently visited) in deciding how to care for you. It is important that you work with a healthcare provider to help you understand the next steps you should take.
However, it is possible for this test to give a negative result that is incorrect (false negative) in some people with COVID-19. This means that you could possibly still have COVID- 19 even though the test is negative. If your test result is negative, your healthcare provider will consider the test result together with all other aspects of your medical history (such as symptoms, vaccine status, possible exposures, and geographical location of places you have recently traveled) in deciding how to care for you.
The amount of antigen in a sample may decrease as the duration of illness increases. As days post-symptom onset increase, antigen test results may be more likely to be negative compared to a molecular SARS-CoV-2 test. You may also test negative at the very beginning of your infection before you develop symptoms.
If you are unwell, your symptoms are worsening, you develop new symptoms, or you are concerned, it is important that you see your healthcare provider, especially if you belong to a high-risk group (please see FAQ “Who is considered high risk for severe disease?”). Your healthcare provider will consider the test result with all other aspects of your medical history (such as symptoms, vaccine status, possible exposures, local community spread, and places you have recently visited) in deciding how to care for you. It is important that you work with a healthcare provider to help you understand the next steps you should take.
There is a chance that this test can give a positive result that is incorrect (a false positive result).Anyone who receives a positive test result needs to consult a healthcare professional. If you have any doubt about your test result, please discuss it with a healthcare professional. This is especially important if you belong to a high-risk group (See FAQ “Who is considered high risk for severe disease?”) or develop emergency warning signs. The healthcare professional will work with you to determine how best to care for you based on your test result along with your medical history and symptoms.
If you do not have symptoms of COVID-19 and get a positive result, your test results should be confirmed with a molecular SARS-COV-2 test. Positive results from the QuickVue At-Home OTC COVID-19 Test are presumptive in asymptomatic patients, and have a higher risk of being false positives, particularly if you do not have a known SARS-CoV-2 exposure and/or live in an area known to have low numbers of SARS-CoV-2 infections.
For low-risk individuals, the CDC recommends that persons who receive a positive antigen test should isolate until they can be confirmed by a molecular test.
If you do not have symptoms of COVID-19 and get a positive result, your test results should be confirmed with a molecular SARS-COV-2 test. Positive results from the QuickVue At-Home OTC COVID-19 Test are presumptive in asymptomatic patients, and have a higher risk of being false positives, particularly if you do not have a known SARS-CoV-2 exposure and/or live in an area known to have low numbers of SARS-CoV-2 infections.
For low-risk individuals, the CDC recommends that persons who receive a positive antigen test should isolate until they can be confirmed by a molecular test.
No. The QuickVue At-Home OTC COVID-19 Test should not be used in children under the age of two. The test has not been validated for use in this age group and if you are concerned that your under two year-old child has COVID-19 you should see a healthcare provider for advice and further management.
COVID-19 serial testing is when one person is tested for COVID-19 more than once at different points in time, such as every 24 to 72 hours. By testing more frequently, you may detect COVID-19 more quickly and reduce spread of infection. For individuals without symptoms of COVID-19, the BD Veritor™ At-Home COVID-19 Test test is intended to be used for serial testing, or used twice by the same individual over 2 or 3 days with at least 24 hours and no more than 48 hours between tests.
If your first or second test is positive, then proteins from the virus that causes COVID-19 has been found in your sample and you likely have COVID-19. If you test positive with the QuickVue At-Home COVID-19 Test, you should self-isolate and seek follow-up care with your healthcare provider to determine the next steps you should take. You may need additional testing, depending on your personal health history and other factors.
If your first test is negative, you should test again in 24-36 hours. If both your first and second tests are negative, you may not have COVID-19, however, you should follow-up with your healthcare provider if you are at high risk for COVID-19 infection. If you test negative and continue to experience COVID-19 like symptoms of fever, cough and/or shortness of breath you should seek follow up care with your healthcare provider. For example, your healthcare provider may suggest you need another test to determine if you have contracted the virus causing COVID-19. It is important that you work with your healthcare provider to help you understand the next steps you should take.
If your first test is negative, you should test again in 24-36 hours. If both your first and second tests are negative, you may not have COVID-19, however, you should follow-up with your healthcare provider if you are at high risk for COVID-19 infection. If you test negative and continue to experience COVID-19 like symptoms of fever, cough and/or shortness of breath you should seek follow up care with your healthcare provider. For example, your healthcare provider may suggest you need another test to determine if you have contracted the virus causing COVID-19. It is important that you work with your healthcare provider to help you understand the next steps you should take.